AREDS2, FDA warning letters, and GMO labeling: May 2013 in pictures By Stephen DANIELLS 03-Jun-2013 - Last updated on 03-Jun-2013 at 22:33 GMT Facebook Twitter Linkedin Email to a friend There wasn’t a dull moment in May for the US dietary supplements industry, with the highly anticipated AREDS2 data being published, FDA enforcement, and the GMO issue all making headlines. AREDS2, FDA warning letters, and GMO labeling: May 2013 in pictures Combating hidden hunger GMO labeling Prop 65 to change? Cleaning up chondroitin AERs Black cohosh adulteration Optimal synbiotics Warning letters Neptune starts to rebuild Prev 1 2 3 4 5 … 10 Next Related tags Dietary supplements industry Dietary supplement
